Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-05-25

Clinical Trial Update: The Long-Term EVAR Assessment and Follow-Up (LEAF) Study for the AFX2 System

View source ↗

Summary

The LEAF trial update indicates ongoing recruitment for the AFX2 Endovascular System in treating abdominal aortic aneurysm.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • AFX2 Endovascular System

Snippet

Sponsor: Endologix | Conditions: Abdominal Aortic Aneurysm | Status: RECRUITING